Biogen Inc. (NASDAQ:BIIB) is one of the top 10 medical AI companies to buy according to analysts. On July 14, UBS reiterated ...

Biogen Inc. (NASDAQ:BIIB) is one of the top cheap pharmaceutical stocks to buy now. BofA lowered the firm’s price target on ...

Investing.com - 周四美国盘前交易中，渤健 (Biogen) (NASDAQ: BIIB )股价上涨，此前这家制药商发布了好于预期的第一季度收入，并上调了全年指引，部分原因是其阿尔茨海默症药物销售强劲。

Biogen (NASDAQ:BIIB) stock rises as Q2 2025 results surpass expectations, driven by Alzheimer's drug Leqembi developed with ...

百健公司 (Biogen Inc) (NASDAQ: BIIB )于2025年7月31日发布了2025年第二季度财务业绩，展示了超出市场预期的强劲表现，并促使管理层上调全年指引。该公司股价在盘前交易中上涨4.3%至132.08美元，反映了投资者对业绩和前景的乐观情绪。

Q2 2025 Earnings Call Transcript July 31, 2025 Biogen Inc. misses on earnings expectations. Reported EPS is $ EPS, ...

Biogen beat Q2 estimates with cost control and new launches, but MS declines and pipeline risks cloud growth. Find out why ...

Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% ...

Investing.com - Shares of Biogen (NASDAQ:BIIB) rose in premarket U.S. trading on Thursday after the drugmaker posted ...

In the preceding three months, 8 analysts have released ratings for Biogen BIIB -0.98% Get Free Report , presenting a wide ...

While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some ...